Brief: Egalet Corporation launches Acura pharmaceuticals' Oxaydo
09/09/2015 21:15
Sept 9 (Reuters) - Acura Pharmaceuticals Inc: * Egalet corporation launches Acura pharmaceuticals' Oxaydo(TM) * Acura pharmaceuticals inc - Egalet Corporation has commercially launched in United States oxaydo tablets, a product Egalet licensed from Acura * Acura pharmaceuticals inc - oxaydo, an immediate release oxycodone hydrochloride formulation that incorporates acura's patented aversionâ technology * Source text for Eikon ID:nMKWN1nqta ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Acura Pharmaceuticals
See all newsBrief: Acura Pharmaceuticals Received A $250,000 Loan From Abuse Deterrent Pharma, LLC on October 11
Brief: Acura Pharmaceuticals Inc Receives $200,000 Loan From Abuse Deterrent Pharma
Brief: Acura Pharmaceuticals Received $250,000 Loan From AD Pharma For Operations Through End Of April 2023
Brief: Acura Pharmaceuticals, AD Pharma Amend License to LIMITx LTX-03
Insight: Novavax bosses cash out for $46 mln with COVID-19 vaccine trials still under way